한국인에서의 도파민 수용체 유전자 다형성(Dopamine Transporter Gene(DAT1) Polymorphism)과 사회공포증과의 연관성에 관한 예비 연구
Polymorphism of Dopamine Transporter Gene(DAT1) in Korean Social Phobia Patients : Preliminary Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Abstract
Although polymorphism of dopamine transporter gene(DAT1) has been considered to be implicated in the pathogenesis of social phobia, previous investigations have been inconsistent and controversial. The authors investigated the relationship between DAT1 polymorphism and social phobia in Koreans. Methods:DAT1 and alleles of fifty subjects who met DSM-IV criterion of social phobia, and those of age- & sex- matched fifty normal controls in Korea were compared. Additionally, patients were grouped into generalized(33) and nongeneralized(17) types and DAT1 polymorphism was compared with that of age- & sex- matched controls. DAT1 with variable number of tandem repeats(VNTR) were determined by using polymerase chain reaction. To compare the distribution of the DAT1 polymorphism between different groups, Fisher’s exact test was used. Results:There were no significant differences in either genotypic(p=0.451) or allelic(p=0.452) distributions between the social phobia patients and the controls. There also were no differences in genotypic distribution between subtypes of social phobia patients and the controls. Conclusion:We couldn’t find any association between DAT1 polymorphism and social phobia. Further studies including larger number of samples and diverse clinical variables should be conducted to elucidate the present findings
참고문헌 (36)
- Kendler KS,, "The genetic epidemiology of phobias in women: theinterrelationship of agoraphobia, social phobia, situationalphobia, and simple phobia", pp.273~281
- Stein MB, "A direct-interview family study ofgeneralized social phobia. Am J Psychiatry", 155, pp.90~97 (1998)
- Liebowitz MR, "letter to the editor", pp.89~90
- Tiihonen J,, "Dopamine reuptake site densitiesin patients with social phobia", 154, pp.239~242 (1997)
- .Schneier FR,, "Low dopamine D2 receptor bindingpotential in social phobia", 157, pp.457~459 (2000)
- Jaber M,, "The dopaminetransporter: a crucial component regulating dopaminetransmission", 12, pp.629~633 (1997)
- Gainetdinov RR,, "Functional hyperdopominergiain dopamine transporter knock-out mice.", 46, pp.303~311 (1999)
- Jones SR,, "Profound neuronal plasticity inresponse to inactivation of the dopamine transporter", 95, pp.4029~4034 (1998)
- Miller GM, "Polymorphisms in the 3’-untranslatedregion of human and monkey dopamine transportergenes affect reporter gene expression", 7, pp.44~55 (2002)
- Jaber M,, "The dopaminetransporter: A crucial component regulating dopaminetransmission", 12, pp.629~633 (1997)
- Vandenbergh DJ, "maps to chromosome 5p 15", pp.3 1104~1106, Griffin CA
- Vandenbergh DJ,, "Human dopaminetransporter gene: coding region conservation amongnormal, Tourette’s disorder, alcohol dependence andattention-deficit hyperactivity disorder populations", 5, pp.283~292 (2000)
- Bannon MJ,, "The human dopamine transporter gene: gene organization,transcriptional regulation, and potential involvementin neuropsychiatric disorders.", 11, pp.449~455 (2001)
- Blum K, "Association of polymorphisms of dopamineD2 receptor (DRD2) and dopamine transporter(DAT1)genes with schizoid", avoidant behaviors(SAB), molpsychiatry1997;2, pp.2, 239~246
- Rowe DC,, "The relation of the dopaminetransporter gene(DAT1) to symptoms of internalizingdisorders in children", 28, pp.215~225 (1998)
- Sullivan PF, "Novelty seeking and a dopaminetransporter gene polymorphism.", 42, pp.1070~1072 (1997)
- Kennedy JL,, "Dopamine system genes notlinked to social phobia", 11, pp.213~217 (2001)
- Mitchelle RJ, "Distribution of the 3’ VNTRpolymorphism in the human dopamine transporter genein world populations", 72, pp.295~304 (2000)
- Nakatome M,, "Amplification of DAT1(human dopaminetransporter gene) 3’ variable region in the Japanesepopulation.", 45, pp.262~265 (1995)
- Nakatome M,, "Genetic polymorphism of the 3’ VNTRregion of the human dopaminergic function gene DAT1(human dopamine transporter gene) in the Mongolianpopulation.", 68, pp.509~515 (1996)
- Van Velzen CJM, "Generalizedsocial phobia versus avoidant personality disorder:differences in psychopathology, personality trait,and social and occupational functioning", 14, pp.395~411 (2000)
- Risch N, "The future of genetics studiesof complex human diseases", 273, pp.1516~1517 (1996)
- Rivest R,, "Brain dopamine transporter:gender differences and effect of chronic haloperidol", 692, pp.269~272 (1995)
- Bannon MJ,, "Age-related and regional differencesin dopamine transporter mRNA expression inhuman midbrain.", 48, pp.969~977 (1997)
- Terwilliger JD,, "A haplotype-based haplotype relativerisk approach to detecting allelic associations"
- Cook EH Jr,, "Association of attention-deficitdisorder and the dopamine transporter gene", 56, pp.993~998 (1995)
- Gelernter J,, "Population studiesof polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase(TAPOE) mu opioid receptor(OPRM1)and ciliary neurotrophic factor(CNTF)).", 52, pp.289~297 (1998)
- 신동원, "한국인에서 주의력결핍 과잉운동장애 환자와 도파민 수송체 유전자(DAT1) 다형성의 연관성 연구", 신경정신의학, 41(4) (2002), 대한신경정신의학회
- Salokangas RK,, "High levels of dopamineactivity in the basal ganglia of cigarette smokers", 157, pp.632~634 (2000)
- Fowler JS,, "Neuropharmacological actions ofcigarette smoke: Brain monoamine oxidase B(MAO B)inhibition.", ow nd, pp.23~34
- Waldman ID, "Association and linkage of thedopamine transporter gene and attention deficit hyperactivitydisorder in children: Heterogeneity owing todiagnostic subtype and severity", 63, pp.1767~1776 (1998)
- Heinz A, "Genotype influences in vivo dopaminetransporter availability in human striatum", 22, pp.133~139 (2000)
- Jacobsen LK,, "Prediction of dopamine transporterbinding availability by genotype:A preliminary report", 157, pp.1700~1703 (2000)
- Cook EH, "Association of attention-deficitdisorder and the dopamine transporter gene", 56, pp.993~998 (1995)
- Daly G, "Mapping susceptibilityloci in attention deficit hyperactivity disorder:preferential transmission of parental alleles at DAT1,DBH and DRD5 to affected children", 4, pp.192~196 (1999)
- Gill M, "Confirmationof association between attention deficit hyperactivitydisorder and a dopamine transporter polymorphism", 2, pp.311~313
